EFECTOS SECUNDARIOS DE LA TRIAMCINOLONA EN PACIENTES JÓVENES SIDE-EFFECTS OF TRIAMCINOLONE IN YOUNG PATIENTS

Case reports: Intravitreal triamcinolone is being increasingly employed for the treatment of macular diseases. We report two cases of intraocular pressure elevation and cataract formation after intravitreal triamcinolone therapy, and wonder if these complications are more likely when this agent is used in young patients. Intravitreal triamcinolone was injected into both eyes of the two young patients with chronic posterior and intermediate uveitis refractory to peribulbar and oral corticosteroid therapy. Chronic cystoid macular edema improved in both patients, however the intraocular pressure increased, requiring topical antihypertensive therapy, and this was followed by accelerated cataract formation. Discussion: Young age and chronic inflammation could be associated with an intraocular pressure rise and subsequent cataract development after intravitreal triamcinolone (Arch Soc Esp Oftalmol 2006; 81: 405-408).